Skip to main content
SpringerLink
Log in

Clinical Implications of Platelet—Vessel Interaction

  • Published:
Journal of Cardiovascular Translational Research Aims and scope Submit manuscript

Abstract

The interaction of platelets with endothelial and inflammatory cells might trigger atherogenesis. Different pathways are responsible for this contribution of platelets to atherogenesis. A significant association has been described between increased platelet activation and the extent of atherosclerosis. Platelet reactivity also plays a key role in determining outcomes of patients undergoing percutaneous coronary intervention (PCI). Despite dual antiplatelet therapy, platelet reactivity increases early after the procedure proportionally to the degree of vascular damage and endothelial dysfunction induced by coronary interventions, and large increases in platelet reactivity are also associated with an increased risk of periprocedural myonecrosis. The interaction between platelets and vessel wall has important clinical implications, especially in patients treated with PCI. These include the appropriate selection of antiplatelet drugs when more aggressive procedures are needed, the prognostic significance of periprocedural variations of platelet reactivity, and the correct timing for platelet function testing.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Davi, G., & Patrono, C. (2007). Platelet activation and atherothrombosis. The New England Journal of Medicine, 357, 2482–94.

    Article  PubMed  CAS  Google Scholar 

  2. Ombrello, C., Block, R. C., & Morrell, C. N. (2010). Our expanding view of platelet functions and its clinical implications. Journal of Cardiovascular Translational Research, 3, 538–46.

    Article  PubMed  Google Scholar 

  3. Gawaz, M., Neumann, F. J., Dickfeld, T., Reininger, A., Adelsberger, H., Gebhardt, A., et al. (1997). Vitronectin receptor (alpha(v)beta3) mediates platelet adhesion to the luminal aspect of endothelial cells: implications for reperfusion in acute myocardial infarction. Circulation, 96, 1809–18.

    Article  PubMed  CAS  Google Scholar 

  4. Bombeli, T., Schwartz, B. R., & Harlan, J. M. (1998). Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha. The Journal of Experimental Medicine, 187, 329–39.

    Article  PubMed  CAS  Google Scholar 

  5. Gawaz, M., Langer, H., & May, A. E. (2005). Platelets in inflammation and atherogenesis. The Journal of Clinical Investigation, 115, 3378–84.

    Article  PubMed  CAS  Google Scholar 

  6. May, A. E., Seizer, P., & Gawaz, M. (2008). Platelets: inflammatory firebugs of vascular walls. Arteriosclerosis, Thrombosis, and Vascular Biology, 28, s5–10.

    Article  PubMed  CAS  Google Scholar 

  7. Henn, V., Slupsky, J. R., Grafe, M., Anagnostopoulos, I., Forster, R., Muller-Berghaus, G., et al. (1998). CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature, 391, 591–94.

    Article  PubMed  CAS  Google Scholar 

  8. May, A. E., Kalsch, T., Massberg, S., Herouy, Y., Schmidt, R., & Gawaz, M. (2002). Engagement of glycoprotein IIb/IIIa (alpha(IIb)beta3) on platelets upregulates CD40L and triggers CD40L-dependent matrix degradation by endothelial cells. Circulation, 106, 2111–17.

    Article  PubMed  CAS  Google Scholar 

  9. Mayadas, T. N., Johnson, R. C., Rayburn, H., Hynes, R. O., & Wagner, D. D. (1993). Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell, 74, 541–54.

    Article  PubMed  CAS  Google Scholar 

  10. Subramaniam, M., Saffaripour, S., Watson, S. R., Mayadas, T. N., Hynes, R. O., & Wagner, D. D. (1995). Reduced recruitment of inflammatory cells in a contact hypersensitivity response in P-selectin-deficient mice. The Journal of Experimental Medicine, 181, 2277–82.

    Article  PubMed  CAS  Google Scholar 

  11. Husain, S., Andrews, N. P., Mulcahy, D., Panza, J. A., & Quyyumi, A. A. (1998). Aspirin improves endothelial dysfunction in atherosclerosis. Circulation, 97, 716–20.

    Article  PubMed  CAS  Google Scholar 

  12. Heitzer, T., Ollmann, I., Koke, K., Meinertz, T., & Munzel, T. (2003). Platelet glycoprotein IIb/IIIa receptor blockade improves vascular nitric oxide bioavailability in patients with coronary artery disease. Circulation, 108, 536–41.

    Article  PubMed  CAS  Google Scholar 

  13. Jakubowski, A., Chlopicki, S., Olszanecki, R., Jawien, J., Lomnicka, M., Dupin, J. P., et al. (2005). Endothelial action of thienopyridines and thienopyrimidinones in the isolated guinea pig heart. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 72, 139–45.

    Article  PubMed  CAS  Google Scholar 

  14. Ziemianin, B., Olszanecki, R., Uracz, W., Marcinkiewicz, E., & Gryglewski, R. J. (1999). Thienopyridines: effects on cultured endothelial cells. Journal of Physiology and Pharmacology, 50, 597–604.

    PubMed  CAS  Google Scholar 

  15. Heitzer, T., Rudolph, V., Schwedhelm, E., Karstens, M., Sydow, K., Ortak, M., et al. (2006). Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease: evidence for antioxidant and antiinflammatory effects. Arteriosclerosis, Thrombosis, and Vascular Biology, 26, 1648–52.

    Article  PubMed  CAS  Google Scholar 

  16. Warnholtz, A., Ostad, M. A., Velich, N., Trautmann, C., Schinzel, R., Walter, U., et al. (2008). A single loading dose of clopidogrel causes dose-dependent improvement of endothelial dysfunction in patients with stable coronary artery disease: results of a double-blind, randomized study. Atherosclerosis, 196, 689–95.

    Article  PubMed  CAS  Google Scholar 

  17. Muller, O., Hamilos, M., Bartunek, J., Ulrichts, H., Mangiacapra, F., Holz, J. B., et al. (2010). Relation of endothelial function to residual platelet reactivity after clopidogrel in patients with stable angina pectoris undergoing percutaneous coronary intervention. The American Journal of Cardiology, 105, 333–38.

    Article  PubMed  CAS  Google Scholar 

  18. Hamilos, M., Muller, O., Ntalianis, A., Trana, C., Bartunek, J., Sarno, G., et al. (2011). Relationship between peripheral arterial reactive hyperemia and residual platelet reactivity after 600 mg clopidogrel. Journal of Thrombosis and Thrombolysis, 32, 64–71.

    Article  PubMed  CAS  Google Scholar 

  19. Patti, G., Grieco, D., Dicuonzo, G., Pasceri, V., Nusca, A., & Di Sciascio, G. (2011). High versus standard clopidogrel maintenance dose after percutaneous coronary intervention and effects on platelet inhibition, endothelial function, and inflammation results of the ARMYDA-150 mg (antiplatelet therapy for reduction of myocardial damage during angioplasty) randomized study. Journal of the American College of Cardiology, 57, 771–78.

    Article  PubMed  CAS  Google Scholar 

  20. Barbato, E., Bartunek, J., Wyffels, E., Wijns, W., Heyndrickx, G. R., & De Bruyne, B. (2003). Effects of intravenous dobutamine on coronary vasomotion in humans. Journal of the American College of Cardiology, 42, 1596–601.

    Article  PubMed  CAS  Google Scholar 

  21. Barbato, E., Piscione, F., Bartunek, J., Galasso, G., Cirillo, P., De Luca, G., et al. (2005). Role of beta2 adrenergic receptors in human atherosclerotic coronary arteries. Circulation, 111, 288–94.

    Article  PubMed  CAS  Google Scholar 

  22. Methia, N., Andre, P., Denis, C. V., Economopoulos, M., & Wagner, D. D. (2001). Localized reduction of atherosclerosis in von Willebrand factor-deficient mice. Blood, 98, 1424–28.

    Article  PubMed  CAS  Google Scholar 

  23. Egan, K. M., Wang, M., Fries, S., Lucitt, M. B., Zukas, A. M., Pure, E., et al. (2005). Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism. Circulation, 111, 334–42.

    Article  PubMed  CAS  Google Scholar 

  24. Pratico, D., Cyrus, T., Li, H., & FitzGerald, G. A. (2000). Endogenous biosynthesis of thromboxane and prostacyclin in 2 distinct murine models of atherosclerosis. Blood, 96, 3823–26.

    PubMed  CAS  Google Scholar 

  25. Dixon, D. A., Tolley, N. D., Bemis-Standoli, K., Martinez, M. L., Weyrich, A. S., Morrow, J. D., et al. (2006). Expression of COX-2 in platelet-monocyte interactions occurs via combinatorial regulation involving adhesion and cytokine signaling. The Journal of Clinical Investigation, 116, 2727–38.

    PubMed  CAS  Google Scholar 

  26. Barbato, E., Rubattu, S., Bartunek, J., Berni, A., Sarno, G., Vanderheyden, M., et al. (2009). Human coronary atherosclerosis modulates cardiac natriuretic peptide release. Atherosclerosis, 206, 258–64.

    Article  PubMed  CAS  Google Scholar 

  27. Jayachandran, M., Litwiller, R. D., Lahr, B. D., Bailey, K. R., Owen, W. G., Mulvagh, S. L., et al. (2011). Alterations in platelet function and cell-derived microvesicles in recently menopausal women: relationship to metabolic syndrome and atherogenic risk. Journal of Cardiovascular Translational Research, 4, 811–22.

    Article  PubMed  Google Scholar 

  28. Koyama, H., Maeno, T., Fukumoto, S., Shoji, T., Yamane, T., Yokoyama, H., et al. (2003). Platelet P-selectin expression is associated with atherosclerotic wall thickness in carotid artery in humans. Circulation, 108, 524–29.

    Article  PubMed  CAS  Google Scholar 

  29. Fateh-Moghadam, S., Li, Z., Ersel, S., Reuter, T., Htun, P., Plockinger, U., et al. (2005). Platelet degranulation is associated with progression of intima-media thickness of the common carotid artery in patients with diabetes mellitus type 2. Arteriosclerosis, Thrombosis, and Vascular Biology, 25, 1299–303.

    Article  PubMed  CAS  Google Scholar 

  30. Furman, M. I., Benoit, S. E., Barnard, M. R., Valeri, C. R., Borbone, M. L., Becker, R. C., et al. (1998). Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. Journal of the American College of Cardiology, 31, 352–58.

    Article  PubMed  CAS  Google Scholar 

  31. Furman, M. I., Barnard, M. R., Krueger, L. A., Fox, M. L., Shilale, E. A., Lessard, D. M., et al. (2001). Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. Journal of the American College of Cardiology, 38, 1002–06.

    Article  PubMed  CAS  Google Scholar 

  32. Keating, F. K., Whitaker, D. A., Kabbani, S. S., Ricci, M. A., Sobel, B. E., & Schneider, D. J. (2004). Relation of augmented platelet reactivity to the magnitude of distribution of atherosclerosis. The American Journal of Cardiology, 94, 725–28.

    Article  PubMed  Google Scholar 

  33. Mangiacapra, F., De Bruyne, B., Muller, O., Trana, C., Ntalianis, A., Bartunek, J., et al. (2010). High residual platelet reactivity after clopidogrel: extent of coronary atherosclerosis and periprocedural myocardial infarction in patients with stable angina undergoing percutaneous coronary intervention. JACC. Cardiovascular Interventions, 3, 35–40.

    Article  PubMed  Google Scholar 

  34. Tcheng, J. E., Lim, I. H., Srinivasan, S., Jozic, J., Gibson, C. M., O’Shea, J. C., et al. (2009). Stent parameters predict major adverse clinical events and the response to platelet glycoprotein IIb/IIIa blockade: findings of the ESPRIT trial. Circulation. Cardiovascular Interventions, 2, 43–51.

    Article  PubMed  Google Scholar 

  35. Wang, T. H., Bhatt, D. L., Fox, K. A., Steinhubl, S. R., Brennan, D. M., Hacke, W., et al. (2007). An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial. European Heart Journal, 28, 2200–07.

    Article  PubMed  Google Scholar 

  36. Mangiacapra, F., Barbato, E., Patti, G., Gatto, L., Vizzi, V., Ricottini, E., et al. (2010). Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary intervention. JACC. Cardiovascular Interventions, 3, 318–23.

    Article  PubMed  Google Scholar 

  37. Mangiacapra, F., Patti, G., Peace, A., Gatto, L., Vizzi, V., Ricottini, E., et al. (2010). Comparison of platelet reactivity and periprocedural outcomes in patients with versus without diabetes mellitus and treated with clopidogrel and percutaneous coronary intervention. The American Journal of Cardiology, 106, 619–23.

    Article  PubMed  CAS  Google Scholar 

  38. Breet, N. J., van Werkum, J. W., Bouman, H. J., Kelder, J. C., Ruven, H. J., Bal, E. T., et al. (2010). Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation. JAMA: The Journal of the American Medical Association, 303, 754–62.

    Article  CAS  Google Scholar 

  39. Mangiacapra, F., Patti, G., Barbato, E., Peace, A. J., Ricottini, E., Vizzi, V., et al. (2012). A therapeutic window for platelet reactivity for patients undergoing elective percutaneous coronary intervention: results of the ARMYDA-PROVE (antiplatelet therapy for reduction of MYocardial damage during angioplasty-platelet reactivity for outcome validation effort) study. JACC. Cardiovascular Interventions, 5, 281–89.

    Article  PubMed  Google Scholar 

  40. Mehta, S. R., Yusuf, S., Peters, R. J., Bertrand, M. E., Lewis, B. S., Natarajan, M. K., et al. (2001). Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. The Lancet, 358, 527–33.

    Article  CAS  Google Scholar 

  41. Steinhubl, S. R., Berger, P. B., Mann, J. T., Fry, E. T., DeLago, A., Wilmer, C., et al. (2002). Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA: The Journal of the American Medical Association, 288, 2411–20.

    Article  CAS  Google Scholar 

  42. Saito, Y., Wada, H., Yamamuro, M., Inoue, A., Shimura, M., Hiyoyama, K., et al. (1999). Changes of plasma hemostatic markers during percutaneous transluminal coronary angioplasty in patients with chronic coronary artery disease. American Journal of Hematology, 61, 238–42.

    Article  PubMed  CAS  Google Scholar 

  43. Serrano, C. V. J., Ramires, J. A., Venturinelli, M., Arie, S., D'Amico, E., Zweier, J. L., et al. (1997). Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression. Evidence of inflammatory responses in coronary angioplasty. Journal of the American College of Cardiology, 29, 1276–83.

    Article  PubMed  CAS  Google Scholar 

  44. Scharf, R. E., Tomer, A., Marzec, U. M., Teirstein, P. S., Ruggeri, Z. M., & Harker, L. A. (1992). Activation of platelets in blood perfusing angioplasty-damaged coronary arteries. Flow cytometric detection. Arterioscler Thromb, 12, 1475–87.

    Article  CAS  Google Scholar 

  45. Gurbel, P. A., Samara, W. M., & Bliden, K. P. (2004). Failure of clopidogrel to reduce platelet reactivity and activation following standard dosing in elective stenting: implications for thrombotic events and restenosis. Platelets, 15, 95–99.

    Article  PubMed  CAS  Google Scholar 

  46. Matetzky, S., Shenkman, B., Guetta, V., Shechter, M., Beinart, R., Goldenberg, I., et al. (2004). Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation, 109, 3171–75.

    Article  PubMed  CAS  Google Scholar 

  47. Siller-Matula, J. M., Haberl, K., Prillinger, K., Panzer, S., Lang, I., & Jilma, B. (2009). The effect of antiplatelet drugs clopidogrel and aspirin is less immediately after stent implantation. Thrombosis Research, 123, 874–80.

    Article  PubMed  CAS  Google Scholar 

  48. Mangiacapra, F., Bartunek, J., Bijnens, N., Peace, A. J., Dierickx, K., Bailleul, E., et al. (2012). Peri-procedural variations of platelet reactivity during elective percutaneous coronary intervention. Journal of Thrombosis and Haemostasis, 10(12), 2452–61.

    Article  PubMed  CAS  Google Scholar 

  49. Price, M. J., Berger, P. B., Teirstein, P. S., Tanguay, J. F., Angiolillo, D. J., Spriggs, D., et al. (2011). Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial. JAMA: The Journal of the American Medical Association, 305, 1097–105.

    Article  CAS  Google Scholar 

  50. Collet, J. P., Cuisset, T., Range, G., et al. (2012). Bedside monitoring to adjust antiplatelet therapy for coronary stenting. The New England Journal of Medicine, 367(22), 2100–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiovascular Center Aalst, OLV Clinic, Moorselbaan 164, 9300, Aalst, Belgium

    Fabio Mangiacapra & Emanuele Barbato

Authors
  1. Fabio Mangiacapra
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emanuele Barbato
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Emanuele Barbato.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mangiacapra, F., Barbato, E. Clinical Implications of Platelet—Vessel Interaction. J. of Cardiovasc. Trans. Res. 6, 310–315 (2013). https://doi.org/10.1007/s12265-012-9441-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12265-012-9441-0

Keywords

Search

Navigation